AMGN vs ELV
By Alex · Tickerpine
Amgen Inc. vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | ELV |
|---|---|---|
| Price | $416.18 | $399.14 |
| Market cap | $225.15B | $86.56B |
| P/E ratio | 25.7 | 17.3 |
| ROE | 91.47% | 11.13% |
| Profit margin | 22.95% | 2.47% |
| Revenue growth | 9.50% | 1.40% |
| Dividend yield | 2.43% | 1.76% |
| Beta | 0.41 | 0.69 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs ELV in plain English
- AMGN is the bigger company — about 2.6× the market cap of ELV.
- ELV is cheaper on earnings (P/E 17.3 vs 25.7).
- AMGN earns a higher return on equity (91% vs 11%).
- AMGN is growing revenue faster (10% vs 1%).
- AMGN has the higher dividend yield (2.43% vs 1.76%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.